‘On the same level’: facilitators’ experiences running a drug user-led safer injecting education campaign
Tóm tắt
Unsafe injection practices play a major role in elevated rates of morbidity and mortality among people who inject drugs (IDU). There is growing interest in the direct involvement of IDU in interventions that seek to address unsafe injecting. This study describes a drug user-led safer injecting education campaign, and explores facilitators’ experiences delivering educational workshops.
We conducted semi-structured qualitative interviews with 8 members of the Injection Support (IS) Team who developed and facilitated a series of safer injecting education workshops. Interviews explored facilitator’s perceptions of the workshops, experiences being a facilitator, and perspectives on the educational campaign. Interviews were transcribed verbatim and a thematic analysis was conducted.
IS Team facilitators described how the workshop’s structure and content enabled effective communication of information about safer injecting practices, while targeting the unsafe practices of workshop participants. Facilitators’ identity as IDU enhanced their ability to relate to workshop participants and communicate educational messages in language accessible to workshop participants. Facilitators reported gaining knowledge and skills from their involvement in the campaign, as well as positive feelings about themselves from the realization that they were helping people to protect their health. Overall, facilitators felt that this campaign provided IDU with valuable information, although facilitators also critiqued the campaign and suggested improvements for future efforts.
This study demonstrates the feasibility of involving IDU in educational initiatives targeting unsafe injecting. Findings illustrate how IDU involvement in prevention activities improves relevance and cultural appropriateness of interventions while providing individual, social, and professional benefits to those IDU delivering education.
Từ khóa
Tài liệu tham khảo
Webb L, Oyefeso A, Schifano F, Cheeta S, Pollard M, Ghodse AH: Cause and manner of death in drug-related fatality: an analysis of drug-related deaths recorded by coroners in england and wales in 2000. Drug Alcohol Depend. 2003, 72: 67-74. 10.1016/S0376-8716(03)00191-1.
Darke S, Hall W: Heroin overdose: research and evidence-based intervention. J Urban Health. 2003, 80: 189-200. 10.1093/jurban/jtg022.
HIV Prevention among injecting drug users.http://data.unaids.org/pub/InformationNote/2009/20090518_hiv_prevention_among_idus_final_en.pdf,
Copeland L, Budd J, Robertson JR, Elton RA: Changing patterns in causes of death in a cohort of injecting drug users, 1980–2001. Arch Intern Med. 2004, 164: 1214-1220. 10.1001/archinte.164.11.1214.
Hulse GK, English DR, Milne E, Holman CDJ: The quantification of mortality resulting from the regular use of illicit opiates. Addiction. 1999, 94: 221-229. 10.1046/j.1360-0443.1999.9422216.x.
Aceijas C, Rhodes T: Global estimates of prevalence of HCV infection among injecting drug users. Int J Drug Policy. 2007, 18: 352-358. 10.1016/j.drugpo.2007.04.004.
Gordon RJ, Lowy FD: Bacterial infections in drug users. N Engl J Med. 2005, 353: 1945-1954. 10.1056/NEJMra042823.
Grund JP: The eye of the needle: an ethno-epidemiological analysis of injecting drug use. Injecting illicit drugs. Edited by: Pates R, McBride A, Arnold K. 2005, Malden: Blackwell Publishing Inc, 11-32.
Pieper B, Kirsner RS, Templin TN, Birk TJ: Injection drug use: an understudied cause of venous disease. Arch Dermatol. 2007, 143: 1305-1309. 10.1001/archderm.143.10.1305.
Mathers BM, Degenhardt L, Ali H, Wiessing L, Hickman M, Mattick RP, Myers B, Ambekar A, Strathdee SA: HIV prevention, treatment, and care services for people who inject drugs: a systematic review of global, regional, and national coverage. Lancet. 2010, 375: 1014-1028. 10.1016/S0140-6736(10)60232-2.
Des Jarlais DC, Arasteh K, Hagan H, McKnight C, Perlman DC, Friedman SR: Persistence and change in disparities in HIV infection among injection drug users in New york city after large-scale syringe exchange programs. Am J Public Health. 2009, 99: S445-S451. 10.2105/AJPH.2008.159327.
Wodak A, Cooney A: Do needle syringe programs reduce HIV infection among injecting drug users: a comprehensive review of the international evidence. Subst Use Misuse. 2006, 41: 777-813. 10.1080/10826080600669579.
Needle RH, Burrows D, Friedman SR, Dorabjee J, Touze G, Badrieva L, Grund JPC, Kumar MS, Nigro L, Manning G, Latkin C: Effectiveness of community-based outreach in preventing HIV/AIDS among injecting drug users. Int J Drug Policy. 2005, 16: S45-S57.
Coyle SL, Needle RH, Normand J: Outreach-based HIV prevention for injecting drug users: a review of published outcome data. Public Health Rep. 1998, 113 (Suppl 1): 19-30.
Hedrich D: European report on drug consumption rooms.http://www.centromedicinapreventiva.org/comunicazioni/news/ven2203045.pdf,
Kaldor J, Lapsley H, Mattick RP, Weatherburn D, Wilson A: Final report of the evaluation of the sydney medically supervised injecting centre.http://www.indro-online.de/sydneyfinalreport.pdf,
Kerr T, Kimber J, Debeck K, Wood E: The role of safer injection facilities in the response to HIV/AIDS among injection drug users. Curr HIV/AIDS Rep. 2007, 4: 158-164. 10.1007/s11904-007-0023-8.
Zule WA, Costenbader EC, Coomes CM, Wechsberg WM: Effects of a hepatitis C virus educational intervention or a motivational intervention on alcohol use, injection drug use, and sexual risk behaviors among injection drug users. Am J Public Health. 2009, 99 (Suppl 1): S180-186.
Purcell DW, Garfein RS, Latka MH, Thiede H, Hudson S, Bonner S, Golub ET, Ouellet LJ: Development, description, and acceptability of a small-group, behavioral intervention to prevent HIV and hepatitis C virus infections among young adult injection drug users. Drug Alcohol Depend. 2007, 91 (Suppl 1): S73-80.
Abou-Saleh M, Davis P, Rice P, Checinski K, Drummond C, Maxwell D, Godfrey C, John C, Corrin B, Tibbs C, Oyefeso A, de Ruiter M, Ghodse H: The effectiveness of behavioural interventions in the primary prevention of hepatitis C amongst injecting drug users: a randomised controlled trial and lessons learned. Harm Reduct J. 2008, 5: 25-10.1186/1477-7517-5-25.
Thiede H, Hagan H, Campbell JV, Strathdee SA, Bailey SL, Hudson SM, Kapadia F, Garfein RS: Prevalence and correlates of indirect sharing practices among young adult injection drug users in five U.S. Cities. Drug Alcohol Depend. 2007, 91 (Suppl 1): S39-47.
Heimer R, Clair S, Grau LE, Bluthenthal RN, Marshall PA, Singer M: Hepatitis-associated knowledge is low and risks are high among HIV-aware injection drug users in three US cities. Addiction. 2002, 97: 1277-1287. 10.1046/j.1360-0443.2002.t01-1-00211.x.
Fairbairn N, Small W, Van Borek N, Wood E, Kerr T: Social structural factors that shape assisted injecting practices among injection drug users in vancouver, Canada: a qualitative study. Harm Reduct J. 2010, 7: 20-10.1186/1477-7517-7-20.
Debeck K, Small W, Wood E, Li K, Montaner J, Kerr T: Public injecting among a cohort of injection drug users in vancouver, canada. J Epidemiol Community Health. 2008, 63: 81-86.
Rachlis B, Lloyd-Smith E, Small W, Tobin D, Stone D, Li K, Wood E, Kerr T: Harmful microinjecting practices among a cohort of injection drug users in vancouver canada. Subst Use Misuse. 2010, 45: 1351-1366. 10.3109/10826081003767643.
Hoda Z, Kerr T, Li K, Montaner JSG, Wood E: Prevalence and correlates of jugular injections among injection drug users. Drug Alcohol Rev. 2008, 27: 442-446. 10.1080/09595230802089701.
Latkin CA: Outreach in natural settings: the use of peer leaders for HIV prevention among injecting drug users’ networks. Public Health Rep. 1998, 113 (Suppl 1): 151-159.
Broadhead RS, Heckathorn DD, Weakliem DL, Anthony DL, Madray H, Mills RJ, Hughes J: Harnessing peer networks as an instrument for AIDS prevention: results from a peer-driven intervention. Public Health Rep. 1998, 113 (Suppl 1): 42-57.
Booth RE, Lehman WEK, Latkin CA, Brewster JT, Sinitsyna L, Dvoryak S: Use of a peer leader intervention model to reduce needle-related risk behaviors among drug injectors in ukraine. J Drug Issues. 2009, 39: 607-625. 10.1177/002204260903900307.
Weeks MR, Li J, Dickson-Gomez J, Convey M, Martinez M, Radda K, Clair S: Outcomes of a peer HIV prevention program with injection drug and crack users: the risk avoidance partnership. Subst Use Misuse. 2009, 44: 253-281. 10.1080/10826080802347677.
Broadhead R, Hammett TM, Kling R, Ngu D, Liu W, Chen Y, Ngoc Quyen H, Thanh Binh K, Van Tren H, Borch C, Gauchat G, Des Jarlais DC: Peer-driven interventions in vietnam and china to prevent HIV: a pilot study targeting injection drug users. J Drug Issues. 2009, 39: 829-850. 10.1177/002204260903900403.
Broadhead RS, Volkanevsky VL, Rydanova T, Ryabkova M, Borch C, van Hulst Y, Fullerton A, Sergeyev B, Heckathorn DD: Peer-driven HIV interventions for drug injectors in russia: first year impact results of a field experiment. Int J Drug Policy. 2006, 17: 379-392. 10.1016/j.drugpo.2006.06.001.
Dickson-Gomez J, Weeks M, Martinez M, Convey M: Times and places: process evaluation of a peer-led HIV prevention intervention. Subst Use Misuse. 2006, 41: 669-690. 10.1080/10826080500411403.
Grund JP, Blanken P, Adriaans NF, Kaplan CD, Barendregt C, Meeuwsen M: Reaching the unreached: targeting hidden IDU populations with clean needles via known user groups. J Psychoactive Drugs. 1992, 24: 41-47. 10.1080/02791072.1992.10471617.
Carruthers S: The organization of a community: community-based prevention of injecting drug use-related health problems. Subst Use Misuse. 2007, 42: 1971-1977. 10.1080/10826080701533302.
Crofts N, Herkt D: A history of peer-based drug-user groups in australia. J Drug Issues. 1995, 25: 599-616.
Trautmann F: Peer support as a method of risk reduction in injecting drug-user communities: experiences in dutch projects and the “european peer support project”. J Drug Issues. 1995, 25: 617-628.
Friedman SR, de Jong W, Rossi D, Touze G, Rockwell R, Des Jarlais DC, Elovich R: Harm reduction theory: users’ culture, micro-social indigenous harm reduction, and the self-organization and outside-organizing of users’ groups. Int J Drug Policy. 2007, 18: 107-117. 10.1016/j.drugpo.2006.11.006.
Kerr T, Hayashi K, Fairbairn N, Kaplan K, Suwannawong P, Zhang R, Wood E: Expanding the reach of harm reduction in thailand: experiences with a drug user-run drop-in centre. Int J Drug Policy. 2010, 21: 255-258. 10.1016/j.drugpo.2009.08.002.
Kerr T, Small W, Peeace W, Douglas D, Pierre A, Wood E: Harm reduction by a “user-run” organization: a case study of the vancouver area network of drug users (VANDU). Int J Drug Policy. 2006, 17: 61-69. 10.1016/j.drugpo.2006.01.003.
Kerr T, Oleson M, Tyndall MW, Montaner J, Wood E: A description of a peer-run supervised injection site for injection drug users. J Urban Health. 2005, 82: 267-275. 10.1093/jurban/jti050.
Wood E, Kerr T, Spittal PM, Small W, Tyndall MW, O’Shaughnessy MV, Schechter MT: An external evaluation of a peer-run “unsanctioned” syringe exchange program. J Urban Health. 2003, 80: 455-464. 10.1093/jurban/jtg052.
Hayashi K, Wood E, Wiebe L, Qi J, Kerr T: An external evaluation of a peer-run outreach-based syringe exchange in vancouver, canada. Int J Drug Policy. 2010, 21: 418-421. 10.1016/j.drugpo.2010.03.002.
Freire P: Pedagogy of the oppressed. 2000, New York: Continuum, 30
Sauve VL: From one educator to another: a window on participatory education. 1987, Edmonton: Grant MacEwan Community College
Harris GE: Practicing HIV/AIDS community-based research. AIDS Care. 2006, 18: 731-738. 10.1080/09540120500307735.
Harper GW, Salina DD: Building collaborative partnerships to improve community-based HIV prevention research. J Prev Interv Community. 2000, 19: 1-20.
Sandelowski M: Focus on research methods: whatever happened to qualitative description?. Res Nurs Health. 2000, 23: 334-340. 10.1002/1098-240X(200008)23:4<334::AID-NUR9>3.0.CO;2-G.
Glaser B, Strauss A: The discovery of grounded theory: strategies for qualitative research. 1967, New York: Aldine De Gruyter
Corbin J, Strauss A: Basics of qualitative research. 2008, Los Angeles: Sage, 3
Friedman SR, Maslow C, Bolyard M, Sandoval M, Mateu-Gelabert P, Neaigus A: Urging others to be healthy: “intravention” by injection drug users as a community prevention goal. AIDS Educ Prev. 2004, 16: 250-263. 10.1521/aeap.16.3.250.35439.
Broadhead RS, Heckathorn DD, Grund JC, Stern LS, Anthony DL: Drug users versus outreach workers in combating AIDS: preliminary results of a peer-driven intervention. J Drug Issues. 1995, 25: 531-564.
Convey MR, Dickson-Gomez J, Weeks MR, Li J: Altruism and peer-led HIV prevention targeting heroin and cocaine users. Qual Health Res. 2010, 20: 1546-1557. 10.1177/1049732310375818.
Latkin CA, Sherman S, Knowlton A: HIV prevention among drug users: outcome of a network-oriented peer outreach intervention. Health Psychol. 2003, 22: 332-339.